David P. Schenkein
2015
In 2015, David P. Schenkein earned a total compensation of $10.1M as President and Chief Executive Officer at Agios Pharmaceuticals, a 132% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $295,000 |
|---|---|
| Option Awards | $9,290,670 |
| Salary | $517,500 |
| Other | $10,052 |
| Total | $10,113,222 |
Schenkein received $9.3M in option awards, accounting for 92% of the total pay in 2015.
Schenkein also received $295K in non-equity incentive plan, $517.5K in salary and $10.1K in other compensation.
Rankings
In 2015, David P. Schenkein's compensation ranked 494th out of 13,638 executives tracked by ExecPay. In other words, Schenkein earned more than 96.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 494 out of 13,638 | 96th |
Division Manufacturing | 166 out of 5,187 | 97th |
Major group Chemicals And Allied Products | 66 out of 1,857 | 96th |
Industry group Drugs | 52 out of 1,531 | 97th |
Industry Pharmaceutical Preparations | 41 out of 1,179 | 97th |
Source: SEC filing on April 18, 2018.
Schenkein's colleagues
We found four more compensation records of executives who worked with David P. Schenkein at Agios Pharmaceuticals in 2015.